Barbara Ann Karmanos Cancer Institute
Clinical trials sponsored by Barbara Ann Karmanos Cancer Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Diabetes drug could help rare kidney disease patients Results expected Apr 2027 (estimated)
- Could electromagnetic waves help shrink breast tumors before surgery? Results expected Apr 2027 (estimated)
- Could electromagnetic fields help fight breast cancer? Results expected May 2027 (estimated)
- Talking money with your oncologist: a new tool to ease Cancer's financial toll Results expected Jul 2027 (estimated)
- Personalized cancer care: genetic analysis may unlock targeted treatments for advanced lung cancer Results expected Jul 2027 (estimated)
-
Can a primer drug make chemotherapy work better for frail head and neck cancer patients?
Disease control Not yet recruitingThis phase 2 trial tests whether giving toripalimab first can prime head and neck cancer tumors to respond better to the chemotherapy drug paclitaxel. The study enrolls 22 patients with metastatic or incurable head and neck squamous cell carcinoma who have a reduced performance s…
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a genetic trait stop chemotherapy from working? a trial aims to fix that
Disease control Not yet recruitingThis trial is testing whether a new dosing algorithm can help people with a genetic trait called Duffy-null get the full benefit of chemotherapy. Many people of African or Middle Eastern descent naturally have lower white blood cell counts (Duffy-null neutropenia), which can lead…
Phase 1/2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a radiofrequency device help fight advanced breast cancer?
Disease control Not yet recruitingThis pilot study tests whether adding a device called TheraBionic P1 to standard treatment can help women with metastatic triple negative breast cancer who have already tried two prior treatments. The device delivers low-level radiofrequency electromagnetic fields and is used alo…
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
A new PET scan tracks brain tumors by their appetite for tryptophan
Diagnosis Not yet recruitingThis trial is testing whether a special PET/CT scan that uses a radioactive form of tryptophan can provide better information about gliomas (a type of brain tumor) than standard MRI. The study has three parts: seeing if the scan can better define the tumor for radiation planning,…
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC